Rituxan for Hairy Cell Leukemia
Recent literature suggests that a subgroup of Hairy Cell Leukemia(HCL), sometimes called Variant Hairy Cell(HCL-V) may in fact be a different type of Lymphoma and not Hairy Cell, and that it may respond to rituximab to a much higher extent than common Hairy Cell does. It is what was called Leukemic Reticuloendotheliosis in the past. It accounts for approximately 0.4% of chronic lymphoid malignancies and 10% of all HCl cases. In contrast to HCl-C,
Read more